These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21336657)

  • 1. A preference-based measure of health: the VR-6D derived from the veterans RAND 12-Item Health Survey.
    Selim AJ; Rogers W; Qian SX; Brazier J; Kazis LE
    Qual Life Res; 2011 Oct; 20(8):1337-47. PubMed ID: 21336657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the Performance of 2 Health Utility Measures in the Medicare Health Outcome Survey (HOS).
    Jia H; Lubetkin EI; DeMichele K; Stark DS; Zack MM; Thompson WW
    Med Decis Making; 2018 Nov; 38(8):983-993. PubMed ID: 30403580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new algorithm to build bridges between two patient-reported health outcome instruments: the MOS SF-36® and the VR-12 Health Survey.
    Selim A; Rogers W; Qian S; Rothendler JA; Kent EE; Kazis LE
    Qual Life Res; 2018 Aug; 27(8):2195-2206. PubMed ID: 29675690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of direct-measured and derived short form six dimensions (SF-6D) health preference values among chronic hepatitis B patients.
    Wong CK; Lam ET; Lam CL
    Qual Life Res; 2013 Dec; 22(10):2973-81. PubMed ID: 23564621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis.
    Harrison MJ; Lunt M; Verstappen SM; Watson KD; Bansback NJ; Symmons DP
    Health Qual Life Outcomes; 2010 Feb; 8():21. PubMed ID: 20149253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A; Green C; Telford C; Zajicek J; Wright D
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the relationship between the EQ-5D, SF-6D, HAQ and disease activity in inflammatory arthritis.
    Adams R; Walsh C; Veale D; Bresnihan B; FitzGerald O; Barry M
    Pharmacoeconomics; 2010; 28(6):477-87. PubMed ID: 20465316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting health-utility scores from the Cervical Spine Outcomes Questionnaire in a multicenter nationwide study of anterior cervical spine surgery.
    Skolasky RL; Carreon LY; Anderson PA; Albert TJ; Riley LH
    Spine (Phila Pa 1976); 2011 Dec; 36(25):2211-6. PubMed ID: 21343870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring outcomes for the Medicare Advantage program: methods and application of the VR-12 for evaluation of plans.
    Kazis LE; Selim AJ; Rogers W; Qian SX; Brazier J
    J Ambul Care Manage; 2012; 35(4):263-276. PubMed ID: 22955087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating utilities for chronic kidney disease, using SF-36 and SF-12-based measures: challenges in a population of veterans with diabetes.
    Rajan M; Lai KC; Tseng CL; Qian S; Selim A; Kazis L; Pogach L; Sinha A
    Qual Life Res; 2013 Feb; 22(1):53-64. PubMed ID: 22392523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of cancer and other chronic medical conditions with SF-6D preference-based scores in Medicare beneficiaries.
    Hays RD; Reeve BB; Smith AW; Clauser SB
    Qual Life Res; 2014 Mar; 23(2):385-91. PubMed ID: 23990395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life in cochlear implantees: comparing utility values obtained through the Medical Outcome Study Short-Form Survey-6D and the Health Utility Index Mark 3.
    Arnoldner C; Lin VY; Bresler R; Kaider A; Kuthubutheen J; Shipp D; Chen JM
    Laryngoscope; 2014 Nov; 124(11):2586-90. PubMed ID: 24536018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders.
    Richardson SS; Berven S
    Spine J; 2012 Jan; 12(1):55-62. PubMed ID: 22209244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure.
    Kontodimopoulos N; Argiriou M; Theakos N; Niakas D
    Eur J Health Econ; 2011 Aug; 12(4):383-91. PubMed ID: 20473544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the short form-6D preference-based index using the eight mean short form-36 health dimension scores: estimating preference-based health-related utilities when patient level data are not available.
    Ara R; Brazier J
    Value Health; 2009; 12(2):346-53. PubMed ID: 18647248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
    McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
    J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index.
    O'Brien BJ; Spath M; Blackhouse G; Severens JL; Dorian P; Brazier J
    Health Econ; 2003 Nov; 12(11):975-81. PubMed ID: 14601159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index.
    Dan AA; Kallman JB; Srivastava R; Younoszai Z; Kim A; Younossi ZM
    Liver Transpl; 2008 Mar; 14(3):321-6. PubMed ID: 18306356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of health-related quality of life in spine treatment: conversion from SF-36 to VR-12.
    Gornet MF; Copay AG; Sorensen KM; Schranck FW
    Spine J; 2018 Jul; 18(7):1292-1297. PubMed ID: 29501747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.